495

Compound name
Defactinib
Compound Image
Defactinib.png
SMILES
CNC(=O)C1=CC=C(C=C1)NC2=NC=C(C(=N2)NCC3=NC=CN=C3N(C)S(=O)(=O)C)C(F)(F)F
MW
510.50
Brutto
C20H21F3N8O3S
InChI
InChI=1S/C20H21F3N8O3S/c1-24-18(32)12-4-6-13(7-5-12)29-19-28-10-14(20(21,22)23)16(30-19)27-11-15-17(26-9-8-25-15)31(2)35(3,33)34/h4-10H,11H2,1-3H3,(H,24,32)(H2,27,28,29,30)
InChI Key
FWLMVFUGMHIOAA-UHFFFAOYSA-N
Approval Jurisdiction
2022 FDA
Approved for clinical use
Solid Tumours
CAS
1073154-85-4
PubChem CID
25117126
Action
PTK2; Pyk2; MELK
Approved Drug List
1
Commercial Vendor
Pfizer-Verastem